Logo image of FRVIA.PA

FORVIA (FRVIA.PA) Stock Fundamental Analysis

EPA:FRVIA - FR0000121147 - Common Stock

10.98 EUR
+0.01 (+0.05%)
Last: 9/9/2025, 5:29:56 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FRVIA. FRVIA was compared to 28 industry peers in the Automobile Components industry. Both the profitability and financial health of FRVIA have multiple concerns. FRVIA may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FRVIA was profitable.
FRVIA had a positive operating cash flow in the past year.
In the past 5 years FRVIA reported 4 times negative net income.
Each year in the past 5 years FRVIA had a positive operating cash flow.
FRVIA.PA Yearly Net Income VS EBIT VS OCF VS FCFFRVIA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.58%, FRVIA is doing worse than 60.71% of the companies in the same industry.
With a Return On Equity value of -12.49%, FRVIA is not doing good in the industry: 67.86% of the companies in the same industry are doing better.
FRVIA has a Return On Invested Capital (5.70%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for FRVIA is below the industry average of 6.78%.
The 3 year average ROIC (4.67%) for FRVIA is below the current ROIC(5.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.58%
ROE -12.49%
ROIC 5.7%
ROA(3y)-0.36%
ROA(5y)-0.69%
ROE(3y)-2.6%
ROE(5y)-4.25%
ROIC(3y)4.67%
ROIC(5y)4.19%
FRVIA.PA Yearly ROA, ROE, ROICFRVIA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With a Operating Margin value of 4.73%, FRVIA perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
FRVIA's Operating Margin has declined in the last couple of years.
FRVIA's Gross Margin of 13.49% is on the low side compared to the rest of the industry. FRVIA is outperformed by 82.14% of its industry peers.
FRVIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.73%
PM (TTM) N/A
GM 13.49%
OM growth 3Y-1.94%
OM growth 5Y-8.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.47%
GM growth 5Y-0.92%
FRVIA.PA Yearly Profit, Operating, Gross MarginsFRVIA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FRVIA is creating some value.
FRVIA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, FRVIA has more shares outstanding
Compared to 1 year ago, FRVIA has an improved debt to assets ratio.
FRVIA.PA Yearly Shares OutstandingFRVIA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
FRVIA.PA Yearly Total Debt VS Total AssetsFRVIA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

FRVIA has an Altman-Z score of 1.19. This is a bad value and indicates that FRVIA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.19, FRVIA is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
The Debt to FCF ratio of FRVIA is 12.32, which is on the high side as it means it would take FRVIA, 12.32 years of fcf income to pay off all of its debts.
FRVIA's Debt to FCF ratio of 12.32 is in line compared to the rest of the industry. FRVIA outperforms 46.43% of its industry peers.
FRVIA has a Debt/Equity ratio of 2.72. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.72, FRVIA is doing worse than 89.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.72
Debt/FCF 12.32
Altman-Z 1.19
ROIC/WACC1.04
WACC5.46%
FRVIA.PA Yearly LT Debt VS Equity VS FCFFRVIA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

FRVIA has a Current Ratio of 0.98. This is a bad value and indicates that FRVIA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of FRVIA (0.98) is worse than 78.57% of its industry peers.
A Quick Ratio of 0.79 indicates that FRVIA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.79, FRVIA is doing worse than 60.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.79
FRVIA.PA Yearly Current Assets VS Current LiabilitesFRVIA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 259.18% over the past year.
The earnings per share for FRVIA have been decreasing by -20.18% on average. This is quite bad
FRVIA shows a decrease in Revenue. In the last year, the revenue decreased by -0.90%.
The Revenue has been growing by 8.71% on average over the past years. This is quite good.
EPS 1Y (TTM)259.18%
EPS 3YN/A
EPS 5Y-20.18%
EPS Q2Q%11300%
Revenue 1Y (TTM)-0.9%
Revenue growth 3Y19.98%
Revenue growth 5Y8.71%
Sales Q2Q%-0.42%

3.2 Future

Based on estimates for the next years, FRVIA will show a very strong growth in Earnings Per Share. The EPS will grow by 36.02% on average per year.
The Revenue is expected to grow by 1.11% on average over the next years.
EPS Next Y-91.53%
EPS Next 2Y37.42%
EPS Next 3Y36.02%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y-0.25%
Revenue Next 3Y1.11%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FRVIA.PA Yearly Revenue VS EstimatesFRVIA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B 25B
FRVIA.PA Yearly EPS VS EstimatesFRVIA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 3.12, the valuation of FRVIA can be described as very cheap.
Based on the Price/Earnings ratio, FRVIA is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.02. FRVIA is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 4.61, the valuation of FRVIA can be described as very cheap.
FRVIA's Price/Forward Earnings ratio is rather cheap when compared to the industry. FRVIA is cheaper than 92.86% of the companies in the same industry.
FRVIA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.66.
Industry RankSector Rank
PE 3.12
Fwd PE 4.61
FRVIA.PA Price Earnings VS Forward Price EarningsFRVIA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRVIA indicates a somewhat cheap valuation: FRVIA is cheaper than 78.57% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, FRVIA is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.48
EV/EBITDA 2.39
FRVIA.PA Per share dataFRVIA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

FRVIA's earnings are expected to grow with 36.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.42%
EPS Next 3Y36.02%

0

5. Dividend

5.1 Amount

No dividends for FRVIA!.
Industry RankSector Rank
Dividend Yield N/A

FORVIA

EPA:FRVIA (9/9/2025, 5:29:56 PM)

10.98

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-28 2025-07-28/dmh
Earnings (Next)10-20 2025-10-20
Inst Owners35.67%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap2.16B
Analysts72.17
Price Target13.45 (22.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)-15.05%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.59%
PT rev (3m)16.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-96.03%
EPS NY rev (3m)-96.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE 3.12
Fwd PE 4.61
P/S 0.08
P/FCF 2.48
P/OCF 0.82
P/B 0.59
P/tB N/A
EV/EBITDA 2.39
EPS(TTM)3.52
EY32.06%
EPS(NY)2.38
Fwd EY21.67%
FCF(TTM)4.43
FCFY40.33%
OCF(TTM)13.46
OCFY122.57%
SpS136.57
BVpS18.64
TBVpS-29.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -12.49%
ROCE 8.01%
ROIC 5.7%
ROICexc 7.8%
ROICexgc 36.54%
OM 4.73%
PM (TTM) N/A
GM 13.49%
FCFM 3.24%
ROA(3y)-0.36%
ROA(5y)-0.69%
ROE(3y)-2.6%
ROE(5y)-4.25%
ROIC(3y)4.67%
ROIC(5y)4.19%
ROICexc(3y)6.19%
ROICexc(5y)5.9%
ROICexgc(3y)22.61%
ROICexgc(5y)20.29%
ROCE(3y)6.59%
ROCE(5y)6%
ROICexcg growth 3Y4.68%
ROICexcg growth 5Y-6.21%
ROICexc growth 3Y-2.68%
ROICexc growth 5Y-11.4%
OM growth 3Y-1.94%
OM growth 5Y-8.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.47%
GM growth 5Y-0.92%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 2.72
Debt/FCF 12.32
Debt/EBITDA 3
Cap/Depr 86.4%
Cap/Sales 6.61%
Interest Coverage 250
Cash Conversion 79.6%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.79
Altman-Z 1.19
F-Score4
WACC5.46%
ROIC/WACC1.04
Cap/Depr(3y)110.58%
Cap/Depr(5y)102.8%
Cap/Sales(3y)7.99%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)259.18%
EPS 3YN/A
EPS 5Y-20.18%
EPS Q2Q%11300%
EPS Next Y-91.53%
EPS Next 2Y37.42%
EPS Next 3Y36.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.9%
Revenue growth 3Y19.98%
Revenue growth 5Y8.71%
Sales Q2Q%-0.42%
Revenue Next Year-2.33%
Revenue Next 2Y-0.25%
Revenue Next 3Y1.11%
Revenue Next 5YN/A
EBIT growth 1Y-1.49%
EBIT growth 3Y17.66%
EBIT growth 5Y0%
EBIT Next Year170.61%
EBIT Next 3Y46.67%
EBIT Next 5YN/A
FCF growth 1Y57.44%
FCF growth 3Y46.28%
FCF growth 5Y8.26%
OCF growth 1Y0.97%
OCF growth 3Y23.48%
OCF growth 5Y8.09%